Role of Statin Therapy in Primary Prevention of Cardiovascular Disease in Elderly Patients

Show full item record



Permalink

http://hdl.handle.net/10138/302820

Citation

Strandberg , T E 2019 , ' Role of Statin Therapy in Primary Prevention of Cardiovascular Disease in Elderly Patients ' , Current atherosclerosis reports. , vol. 21 , no. 8 , 28 . https://doi.org/10.1007/s11883-019-0793-7

Title: Role of Statin Therapy in Primary Prevention of Cardiovascular Disease in Elderly Patients
Author: Strandberg, Timo E.
Contributor: University of Helsinki, Timo Strandberg / Principal Investigator
Date: 2019-08
Language: eng
Number of pages: 7
Belongs to series: Current atherosclerosis reports.
ISSN: 1523-3804
URI: http://hdl.handle.net/10138/302820
Abstract: Purpose of ReviewHypercholesterolemia and statin treatment are nowadays common among people older than 75years, but clinical heterogeneity in this increasing age group is wide, and treatment decisions may differ from those in younger patients. Aim is to discuss the presentation, modifying factors, and treatment decisions of hypercholesterolemia (usually with statins) in older persons and focusing on primary prevention.Recent FindingsThere are no randomized controlled trials in persons older than 80years at baseline. Randomized controlled trial findings in younger patients and 75+ subgroups and in observational studies support treatment in secondary prevention of atherosclerotic cardiovascular disease (ASCVD), but trial evidence in primary prevention is less clear. Available data do not imply specific harms in older patients, and, therefore, also, judicious primary prevention is possible. However, persons older than 75years are biologically a very heterogeneous group with frequent frailty, comorbid conditions, and multiple concomitant drugs. All these, as well as personal preferences, must be taken into account in treatment decisions.SummaryStatin treatment is only one way to prevent ASCVD in older people. Treatment of hypercholesterolemia should be started far before 75-80years, and there is no need to discontinue statin treatment due to chronological age alone. After 75years, treatment should be started in patients with ASCVD and judiciously in primary prevention. Like all prevention, statin treatment should be discontinued when palliative treatment is started. Ongoing and planned trials in 70+ individuals will give more information about primary prevention in older persons.
Subject: Aged
Cardiovascular
Statin
Primary prevention
OLDER PATIENTS
CHOLESTEROL
ROSUVASTATIN
MORTALITY
EVENTS
AGE
3121 General medicine, internal medicine and other clinical medicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
Role_of_Statin_Therapy_in_Primary_Prevention.pdf 908.5Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record